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Human Immunodeficiency Virus (HIV) and Hepatitis
C Virus (HCV) co-infect five million people worldwide.
HIV-HCV co-infection represents the major cause of
liver related morbidity among the HIV infected patients.
The current HCV standard of care consisting of pegy-
lated a-interferon and ribavirin has variable efficacy and
considerable side-effects. A major step towards a more
efficient and better tolerated therapy has been done by
the recent approval of the first direct acting antivirals
(DAAs) to enter the clinic. Moreover, there are numer-
ous DAAs which are advanced in clinical trials targeting
different steps in the viral life cycle. Due to the variety
and efficacy of HCV drugs in the clinic or in the pipe-
line, there is hope for an interferon free treatment.
However, despite the increased efficacy of DAAs with or
without interferon and ribavirin, viral resistance still
represents an issue. Thus, phenotyping resistance “in
vitro” should help the clinician to better personalize the
HCV treatment. HCV drug resistance phenotyping has
become possible due to the HCV cell culture system.
HCV cell culture (HCVcc) system relies on the JFH-1
strain of genotype 2a which is able to replicate in cell
culture without adaptive mutations. HCVcc system
allows the analysis of every step in the viral life cycle:
replication, secretion and infectivity. Clinically relevant
chimeric viruses are available covering different HCV
genotypes. This allows the “in vitro” evaluation of the
viral fitness starting from patient derived viral
sequences. We are presenting the complementarity
between drug resistance genotyping and HCVcc system
in understanding the mechanisms of HCV drug resis-
tance. The use of a drug resistance phenotyping assay
for clinical purpose will be discussed.
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